Page 1 of 1

Clinician Perspectives on Migraine Treatment, Timing, and Cannabinoids

This short survey explores clinicians’ experiences with acute migraine treatment, timing of intervention, patient self-treatment practices, and cannabis/cannabinoid questions. Responses may be summarized in aggregate or, with your permission, quoted anonymously in future educational writing or a book chapter. Please do not include patient-identifying information. Estimated time: 3–5 minutes.

What best describes your clinical role?

A
B
C
D
E
F
G
H

What is your primary specialty or practice area?

Approximately how often do you encounter patients with migraine?

A
B
C
D
E

In your experience, how important is timing of acute migraine treatment?

A
B
C
D
E

Do you generally encourage patients to treat at the earliest recognizable stage of an attack?

A
B
C
D
E

What factors influence that recommendation? (short answer)

How often do patients ask you about cannabis or cannabinoid products for migraine?

A
B
C
D

Based on your clinical experience, how would you characterize cannabis/cannabinoids for acute migraine?

A
B
C
D
E
F

If you have encountered patients using cannabis for migraine, what outcomes have they reported? (Checkboxes - may select multiple)

What concerns you most about cannabis/cannabinoid treatment for migraine? (Checkboxes - may select multiple)

Do you think the timing of cannabinoid administration could meaningfully influence its effectiveness in acute migraine?

A
B
C
D
E

What evidence would you need before feeling comfortable recommending a cannabinoid treatment for migraine?

What do you think researchers misunderstand or overlook about treating migraine in real clinical practice

Publication permission - May your comments be used in future articles or a book chapter?

A
B
C
D
E